Marksans Pharma Limited has informed the Exchange about Schedule of meet
MARKSANS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Marksans Pharma has informed the stock exchanges about a conference call scheduled for Tuesday, May 20, 2025 at 5:00 PM IST to discuss its audited financial results (standalone and consolidated) for the quarter and full year ended March 31, 2025. The call will be hosted by Elara Securities and will feature Founder, Chairman and Managing Director Mark Saldanha along with Chief Financial Officer Jitendra Sharma. Dial-in access is available for participants in India, the US, UK, Singapore, Hong Kong, and Australia. The presentation, audio recording, and transcript will be uploaded to the company's website after the call.
This is a routine pre-earnings intimation and does not contain any financial figures yet. Investors should watch the May 20 call for Q4 and full-year FY25 results, which could influence the stock's near-term direction depending on the numbers and management commentary.